116 related articles for article (PubMed ID: 7825180)
1. Time-course of toxicity of reactive sulfonamide metabolites.
Rieder MJ; Krause R; Bird IA
Toxicology; 1995 Jan; 95(1-3):141-6. PubMed ID: 7825180
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides.
Rieder MJ; Uetrecht J; Shear NH; Spielberg SP
J Pharmacol Exp Ther; 1988 Feb; 244(2):724-8. PubMed ID: 3346843
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites.
Rieder MJ; Uetrecht J; Shear NH; Cannon M; Miller M; Spielberg SP
Ann Intern Med; 1989 Feb; 110(4):286-9. PubMed ID: 2913915
[TBL] [Abstract][Full Text] [Related]
4. Toxicity of sulfonamide-reactive metabolites in HIV-infected, HTLV-infected, and noninfected cells.
Rieder MJ; Krause R; Bird IA; Dekaban GA
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb; 8(2):134-40. PubMed ID: 7834397
[TBL] [Abstract][Full Text] [Related]
5. Metabolic and chemical origins of cross-reactive immunological reactions to arylamine benzenesulfonamides: T-cell responses to hydroxylamine and nitroso derivatives.
Castrejon JL; Lavergne SN; El-Sheikh A; Farrell J; Maggs JL; Sabbani S; O'Neill PM; Park BK; Naisbitt DJ
Chem Res Toxicol; 2010 Jan; 23(1):184-92. PubMed ID: 19954178
[TBL] [Abstract][Full Text] [Related]
6. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity.
Cribb AE; Miller M; Leeder JS; Hill J; Spielberg SP
Drug Metab Dispos; 1991; 19(5):900-6. PubMed ID: 1686233
[TBL] [Abstract][Full Text] [Related]
7. Hepatic microsomal metabolism of sulfamethoxazole to the hydroxylamine.
Cribb AE; Spielberg SP
Drug Metab Dispos; 1990; 18(5):784-7. PubMed ID: 1981737
[TBL] [Abstract][Full Text] [Related]
8. Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs.
Cribb AE; Miller M; Tesoro A; Spielberg SP
Mol Pharmacol; 1990 Nov; 38(5):744-51. PubMed ID: 2172779
[TBL] [Abstract][Full Text] [Related]
9. Haptenation of sulfonamide reactive metabolites to cellular proteins.
Manchanda T; Hess D; Dale L; Ferguson SG; Rieder MJ
Mol Pharmacol; 2002 Nov; 62(5):1011-26. PubMed ID: 12391263
[TBL] [Abstract][Full Text] [Related]
10. Differential toxicity of reactive metabolites of clindamycin and sulfonamides in HIV-infected cells: influence of HIV infection on clindamycin toxicity in vitro.
Wijsman JA; Dekaban GA; Rieder MJ
J Clin Pharmacol; 2005 Mar; 45(3):346-51. PubMed ID: 15703369
[TBL] [Abstract][Full Text] [Related]
11. Plasma ascorbate deficiency is associated with impaired reduction of sulfamethoxazole-nitroso in HIV infection.
Trepanier LA; Yoder AR; Bajad S; Beckwith MD; Bellehumeur JL; Graziano FM
J Acquir Immune Defic Syndr; 2004 Aug; 36(5):1041-50. PubMed ID: 15247557
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of sulfonamide reactive metabolites: apoptosis and selective toxicity of CD8(+) cells by the hydroxylamine of sulfamethoxazole.
Hess DA; Sisson ME; Suria H; Wijsman J; Puvanesasingham R; Madrenas J; Rieder MJ
FASEB J; 1999 Oct; 13(13):1688-98. PubMed ID: 10506572
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of human T cells with sulfonamides and sulfonamide metabolites.
Castrejon JL; Berry N; El-Ghaiesh S; Gerber B; Pichler WJ; Park BK; Naisbitt DJ
J Allergy Clin Immunol; 2010 Feb; 125(2):411-418.e4. PubMed ID: 20159253
[TBL] [Abstract][Full Text] [Related]
14. Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine.
Bhusari S; Abouraya M; Padilla ML; Pinkerton ME; Drescher NJ; Sacco JC; Trepanier LA
Arch Toxicol; 2010 Aug; 84(8):597-607. PubMed ID: 20221587
[TBL] [Abstract][Full Text] [Related]
15. Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso.
Lavergne SN; Kurian JR; Bajad SU; Maki JE; Yoder AR; Guzinski MV; Graziano FM; Trepanier LA
Toxicology; 2006 May; 222(1-2):25-36. PubMed ID: 16473451
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study.
Lavergne SN; Volkman EM; Maki JE; Yoder AR; Trepanier LA
Toxicology; 2005 Mar; 208(1):63-72. PubMed ID: 15664433
[TBL] [Abstract][Full Text] [Related]
17. Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: implications for differences in adverse drug reactions.
Reilly TP; Woster PM; Svensson CK
J Pharmacol Exp Ther; 1999 Mar; 288(3):951-9. PubMed ID: 10027831
[TBL] [Abstract][Full Text] [Related]
18. Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells.
Burkhart C; von Greyerz S; Depta JP; Naisbitt DJ; Britschgi M; Park KB; Pichler WJ
Br J Pharmacol; 2001 Feb; 132(3):623-30. PubMed ID: 11159714
[TBL] [Abstract][Full Text] [Related]
19. Sulfamethoxazole is metabolized to the hydroxylamine in humans.
Cribb AE; Spielberg SP
Clin Pharmacol Ther; 1992 May; 51(5):522-6. PubMed ID: 1587066
[TBL] [Abstract][Full Text] [Related]
20. Cellular toxicity of sulfamethoxazole reactive metabolites--I. Inhibition of intracellular esterase activity prior to cell death.
Leeder JS; Dosch HM; Spielberg SP
Biochem Pharmacol; 1991 Feb; 41(4):567-74. PubMed ID: 1997005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]